Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Conditions
- Brain and Central Nervous System Tumors
- Lymphoma
- Lymphoproliferative Disorder
- Small Intestine Cancer
- Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
- DRUG: imetelstat sodium
- OTHER: laboratory biomarker analysis
- OTHER: pharmacological study
Sponsor
Children's Oncology Group
Collaborators